Download PDF
February 1, 2016

Richard E. Engler, Ph.D. Interviewed In Nature Biotechnology Article “A face-lift for biotech rules

The ACTA Group

The December 2015 issue of Nature Biotechnology included comments by Richard E. Engler, Ph.D. on keeping biotech rules current with scientific progress in the article “A face-lift for biotech rules begins.”

To stay up to date with technology, Richard Engler, a senior chemist at the environmental law firm Bergeson & Campbell in Washington, DC, suggested that technology stewards be embedded in each of the relevant federal agencies. Their role would be to monitor emerging technologies and hold regular briefings with industry and academic innovators.